55 related articles for article (PubMed ID: 14507073)
1. Immunocytochemical analysis of the tissue location of cytokines (IL-2 and IL-12) in neuroendocrine lung cancer.
Kasprzak A; Przewoźna M; Zabel M; Pankowski J; Surdyk-Zasada J
Folia Morphol (Warsz); 2003; 62(3):301-3. PubMed ID: 14507073
[TBL] [Abstract][Full Text] [Related]
2. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
3. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
6. LKB1 protein expression in neuroendocrine tumors of the lung.
Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
Zaffaroni N; De Polo D; Villa R; Della Porta C; Collini P; Fabbri A; Pilotti S; Daidone MG
J Pathol; 2003 Sep; 201(1):127-33. PubMed ID: 12950025
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
9. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
10. [The tumorlet carcinoid in bronchiectasis-changed lungs. An example of a multifocal, endocrine tumor].
Klinke F; Bosse U; Höfler H
Pneumologie; 1990 Feb; 44 Suppl 1():607-9. PubMed ID: 2367481
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear oncoprotein expression in lung precancer and cancer at various stages of tumor progression studies at the level of light- and electron-immunohistochemistry].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Mazurenko NN; Kiselev FL
Arkh Patol; 1994; 56(6):44-9. PubMed ID: 7605217
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract.
Arvidsson Y; Andersson E; Bergström A; Andersson MK; Altiparmak G; Illerskog AC; Ahlman H; Lamazhapova D; Nilsson O
Endocr Relat Cancer; 2008 Jun; 15(2):569-81. PubMed ID: 18430897
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
14. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
15. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A as a marker of neuroendocrine histogenesis of tumours: an immunoelectron microscopic study with considerations about the influence of fixation and embedding media on immunolabelling.
Leone BE; Taccagni GL; Dell'Antonio G; Cantaboni A
Basic Appl Histochem; 1990; 34(2):143-53. PubMed ID: 2222401
[TBL] [Abstract][Full Text] [Related]
17. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
Saji H; Nakamura H; Awut I; Kawasaki N; Hagiwara M; Ogata A; Hosaka M; Saijo T; Kato Y; Kato H
Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):295-300. PubMed ID: 14672525
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
19. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
[TBL] [Abstract][Full Text] [Related]
20. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
